MitomiRs are microRNA (miRNA) molecules primarily present in mitochondria. Recent studies have shown that mitomiRs regulate multiple oncogenic signaling pathways and target key transporters and enzymes in cellular metabolism. In addition, mitomiRs control the metabolism of cancer cells by regulating the expression of messenger ribonucleic acid (mRNA). Monocarboxylate transporter 1 (MCT1) is an important transport protein involved in the transport of monocarboxylates, especially L-lactate, ketone bodies and pyruvate across the membrane. Studies have shown that the expression of the Mct1 gene is greatly increased in some types of cancer, such as breast cancer. The aim of our study was to compare the expression levels of miR-181c-5p, miR-124-3p and the Mct1 gene between the control group of TS/A mouse mammary adenocarcinoma cells and groups of cells treated with anti-miRs. Anti-miRs are chemically modified RNA molecules designed for specific binding to miRNA molecules and their silencing. Additionaly, we wanted to determine differences in intracellular pH (pHi) values, cytochrome c oxidase activity, as well as cell growth and survival between control cells and cells treated with anti-miRs. The expression of selected mitomiRs and the Mct1 gene was quantified using quantitative real-time polymerase chain reaction (qRT-PCR). We determined differences in pHi values and cytochrome c oxidase activity in TS/A cells. The survival and growth of TS/A cells were monitored using the PrestoBlueTM assay. We have demonstrated that TS/A mouse mammary adenocarcinoma cells express miR-181c-5p, miR-124-3p and Mct1 gene, but we did not demonstrate changes in the expression of the Mct1 gene after treating the selected mitomiRs. We have shown that treating of selected mitomiRs changes the values of pHi and cytochrome c oxidase activity, but does not change the growth and survival of TS/A cells.
|